Eyenovia, Inc. revenue breakdown overview

Eyenovia, Inc. revenue for the last year amounted to 3.79 M USD, the most of which — 3.79 k USD — came from its highest performing source at the moment, Mydcombi and Clobetasol Propionate, the year earlier bringing 14.00 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Eyenovia, Inc. 3.79 k USD, and the year before that — 14.00 M USD.